학술논문
Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine
Document Type
Article
Author
Source
In: Multiple Sclerosis Journal - Experimental, Translational and Clinical . (Multiple Sclerosis Journal - Experimental, Translational and Clinical, April-June 2023, 9(2))
Subject
Language
English
ISSN
20552173